Immediate Impact
1 by Nobel laureates 61 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Amy Flynt being referenced
A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer
2017
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Amy Flynt | 4 | 128 | 96 | 75 | 14 | 296 | |
| Jie Guan | 9 | 65 | 86 | 72 | 23 | 308 | |
| T Weiss | 6 | 66 | 111 | 106 | 15 | 333 | |
| Stephen Ip | 60 | 93 | 87 | 25 | 21 | 327 | |
| Yamini Goyal | 10 | 37 | 67 | 58 | 17 | 290 | |
| Feliciano Chanana Paquissi | 15 | 47 | 119 | 77 | 9 | 282 | |
| Phaedon D. Zavras | 12 | 57 | 105 | 27 | 23 | 305 | |
| Xianzhen Peng | 20 | 50 | 91 | 28 | 16 | 331 | |
| Livia Salmi | 22 | 63 | 57 | 80 | 17 | 324 | |
| Jinhee Lee | 9 | 55 | 34 | 49 | 23 | 217 | |
| V Lakshmaiah | 11 | 108 | 130 | 21 | 16 | 317 |
All Works
Loading papers...